Full name
ANGELINI PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
10.86.Z - Production of homogenized food products and diet food
20.42.Z - Manufacture of cosmetics and toilet preparations
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.1 - Wholesale trade conducted on behalf of others
52.10.B - Warehousing and storage of other goods
70.21.Z - Head office activities and management consultancy
72.19.Z - Scientific research and development activities
73.1 - Advertising
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 8,7 | 19,1 | 15 | -21 |
EBITDA | 9,4 | 18,2 | 12,2 | -33 |
Short time liabilities | 64,3 | 122,8 | 158,4 | 29 |
Equity capital | 73,8 | 65,9 | 62,4 | -5,3 |
Operating profit (EBIT) | 8,8 | 17,4 | 11,3 | -35,1 |
Assets | 145 | 197,2 | 230,3 | 16,8 |
Net profit (loss) | 6,6 | 15,3 | 11,8 | -23 |
Cash | 44,1 | 70 | 74,1 | 5,8 |
Liabilities and provisions for liabilities | 71,2 | 131,3 | 167,9 | 27,9 |
Net income from sale | 254,7 | 352,3 | 403,4 | 14,5 |
Working assets | 141,7 | 191,4 | 224,3 | 17,2 |
Depreciation | 0,7 | 0,8 | 0,9 | 13,3 |
% | % | % | p.p. | |
Profitability of capital | 8,9 | 23,2 | 18,8 | -4,4 |
Equity capital to total assets | 50,9 | 33,4 | 27,1 | -6,3 |
Gross profit margin | 3,4 | 5,4 | 3,7 | -1,7 |
EBITDA Margin | 3,7 | 5,2 | 3 | -2,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 92 | 127 | 143 | 16 |
Current financial liquidity indicator | 2.129199504852295 | 1.471431851387024 | 1.3444410562515259 | -0,2 |
Net dept to EBITDA | -4.653682708740234 | -3.8366010189056396 | -6.064329147338867 | -2,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane